These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32087387)

  • 1. Prospective validation of a clinical prediction score for survival in patients with spinal metastases: the New England Spinal Metastasis Score.
    Schoenfeld AJ; Ferrone ML; Schwab JH; Blucher JA; Barton LB; Tobert DG; Chi JH; Shin JH; Kang JD; Harris MB
    Spine J; 2021 Jan; 21(1):28-36. PubMed ID: 32087387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective comparison of the accuracy of the New England Spinal Metastasis Score (NESMS) to legacy scoring systems in prognosticating outcomes following treatment of spinal metastases.
    Schoenfeld AJ; Ferrone ML; Blucher JA; Agaronnik N; Nguyen L; Tobert DG; Balboni TA; Schwab JH; Shin JH; Sciubba DM; Harris MB
    Spine J; 2022 Jan; 22(1):39-48. PubMed ID: 33741509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the utility of a clinical prediction score regarding 30-day morbidity and mortality following metastatic spinal surgery: the New England Spinal Metastasis Score (NESMS).
    Schoenfeld AJ; Le HV; Marjoua Y; Leonard DA; Belmont PJ; Bono CM; Harris MB
    Spine J; 2016 Apr; 16(4):482-90. PubMed ID: 26409416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the prospective observational study of spinal metastasis treatment (POST).
    Schoenfeld AJ; Blucher JA; Barton LB; Schwab JH; Balboni TA; Chi JH; Shin JH; Kang JD; Harris MB; Ferrone ML
    Spine J; 2020 Apr; 20(4):572-579. PubMed ID: 31712164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the utility of a prognostication model to predict 1-year mortality in patients undergoing radiation therapy for spinal metastases.
    Shi DD; Chen YH; Lam TC; Leonard D; Balboni TA; Schoenfeld A; Skamene S; Cagney DN; Chi JH; Cho CH; Harris M; Ferrone ML; Hertan LM
    Spine J; 2018 Jun; 18(6):935-940. PubMed ID: 29031992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2 Years Following Treatment: Survival and Functional Outcomes.
    Xiong GX; Fisher MWA; Schwab JH; Simpson AK; Nguyen L; Tobert DG; Balboni TA; Shin JH; Ferrone ML; Schoenfeld AJ
    Spine (Phila Pa 1976); 2022 Apr; 47(7):515-522. PubMed ID: 35066537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic scoring system combining the revised Tokuhashi score and the New England spinal metastasis score for preoperative evaluation of spinal metastases.
    Mavritsakis D; Amiot LP
    Front Surg; 2024; 11():1349586. PubMed ID: 38505407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of nutritional status for adverse outcomes after surgery for metastatic spine tumors.
    Rigney GH; Massaad E; Kiapour A; Razak SS; Duvall JB; Burrows A; Khalid SI; De La Garza Ramos R; Tobert DG; Williamson T; Shankar GM; Schoenfeld AJ; Shin JH
    J Neurosurg Spine; 2023 Oct; 39(4):557-567. PubMed ID: 37439458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Prognostic Models to Facilitate Surgical Decision-Making for Patients With Spinal Metastatic Disease.
    Wick JB; Kalistratova VS; Jr DP; Fine JR; Boozé ZL; Holland J; Vander Voort W; Hisatomi LA; Villegas A; Conry K; Ortega B; Javidan Y; Roberto RF; Klineberg EO; Le HV
    Spine (Phila Pa 1976); 2023 Apr; 48(8):567-576. PubMed ID: 36799724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Performance of Prognostic Scores in Patients with Spinal Metastases from Lung Cancer Undergoing Non-surgical Treatment.
    Truong VT; Al-Shakfa F; Roberge D; Masucci GL; Tran TPY; Dib R; Yuh SJ; Wang Z
    Asian Spine J; 2023 Aug; 17(4):739-749. PubMed ID: 37408290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lab data and performance comparison by validating survival prediction models for patients with spinal metastases after radiotherapy.
    Yen HK; Hu MH; Zijlstra H; Groot OQ; Hsieh HC; Yang JJ; Karhade AV; Chen PC; Chen YH; Huang PH; Chen YH; Xiao FR; Verlaan JJ; Schwab JH; Yang RS; Yang SH; Lin WH; Hsu FM
    Radiother Oncol; 2022 Oct; 175():159-166. PubMed ID: 36067909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective evaluation of prognostic factors in metastatic spine disease: serum albumin and primary tumour type are key.
    Cook WH; Baker JF
    ANZ J Surg; 2020 Jun; 90(6):1070-1074. PubMed ID: 32175660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma: which scoring system is most accurate?
    Massaad E; Hadzipasic M; Alvarez-Breckenridge C; Kiapour A; Fatima N; Schwab JH; Saylor P; Oh K; Schoenfeld AJ; Shankar GM; Shin JH
    J Neurosurg Spine; 2020 Oct; 33(4):529-539. PubMed ID: 32502990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory markers as useful prognostic measures for survival in patients with spinal metastases.
    Schoenfeld AJ; Ferrone ML; Passias PG; Blucher JA; Barton LB; Shin JH; Harris MB; Schwab JH
    Spine J; 2020 Jan; 20(1):5-13. PubMed ID: 31125700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with spinal metastasis: a systematic review and meta-analysis.
    Luksanapruksa P; Buchowski JM; Hotchkiss W; Tongsai S; Wilartratsami S; Chotivichit A
    Spine J; 2017 May; 17(5):689-708. PubMed ID: 27988342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical strategy for spinal metastases.
    Tomita K; Kawahara N; Kobayashi T; Yoshida A; Murakami H; Akamaru T
    Spine (Phila Pa 1976); 2001 Feb; 26(3):298-306. PubMed ID: 11224867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival in older patients treated for cervical spine fractures: development of a clinical survival score.
    Cronin PK; Ferrone ML; Marso CC; Stieler EK; Beck AW; Blucher JA; Makhni MC; Simpson AK; Harris MB; Schoenfeld AJ
    Spine J; 2019 Sep; 19(9):1490-1497. PubMed ID: 31125694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting 30-day mortality after surgery for metastatic disease of the spine: the H
    Musharbash FN; Khalifeh JM; Raad M; Puvanesarajah V; Lee SH; Neuman BJ; Kebaish KM
    Eur Spine J; 2023 Jul; 32(7):2513-2520. PubMed ID: 37186159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the SORG algorithm generalize to a contemporary cohort of patients with spinal metastases on external validation?
    Bongers MER; Karhade AV; Villavieja J; Groot OQ; Bilsky MH; Laufer I; Schwab JH
    Spine J; 2020 Oct; 20(10):1646-1652. PubMed ID: 32428674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three predictive scoring systems for morbidity in oncological spine surgery.
    De la Garza Ramos R; Naidu I; Choi JH; Pennington Z; Goodwin CR; Sciubba DM; Shin JH; Yanamadala V; Murthy S; Gelfand Y; Yassari R
    J Clin Neurosci; 2021 Dec; 94():13-17. PubMed ID: 34863427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.